ELIMINATION OF ALLOANTIBODIES BY IMMUNOABLATIVE HIGH-DOSE CYCLOPHOSPHAMIDE 1

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Transplantation

• Publication date

  2001-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-200102150-00025PMID 11233915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoablative High-Dose Cyclophosphamide without Stem-Cell Rescue for Refractory, Severe Autoimmune Disease

  1998cited by this paper
• The UNOS OPTN waiting list and donor registry.

  1998cited by this paper
• Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay

  1997cited by this paper
• Pilot study of HLA alloimmunization after transfusion with pre‐storage leucodepleted blood products in aplastic anaemia

  1997cited by this paper
• Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

  1996cited by this paper
• Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.

  1994cited by this paper
• SUPPRESSION OF HLA‐SPECIFIC ALLOANTIBODIES BY HIGH‐DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg): A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS

  1993cited by this paper
• Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases

  1987cited by this paper
• Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

  1976cited by this paper

• Desensitization for solid organ and hematopoietic stem cell transplantation

  2014cites this paper
• HIGH-DOSE CYCLOPHOSPHAMIDE FOR SEVERE APLASTIC ANEMIA

  2014cites this paper
• Leffell Desensitization for solid organ and hematopoietic stem cell transplantation

  2014cites this paper
• Pulse Cyclophosphamide Therapy in Refractory Warm Autoimmune Hemolytic Anemia: A New Perspective

  2014cites this paper
• Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.

  2013cites this paper
• High-dose cyclophosphamide for autoimmunity and alloimmunity

  2010cites this paper
• Autoimmune enteropathy in children and adults

  2009cites this paper
• Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases

  2008cites this paper
• Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: Advantages and disadvantages

  2008cites this paper
• Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

  2006cites this paper
• Utilisation de doses elevees de medicaments comprenant de l'oxazaphosphorine pour le traitement de troubles immunitaires

  2006cites this paper
• Management of patients with preformed reactive antibodies who are awaiting cardiac transplantation.

  2005cites this paper
• Immunadsorption bei der heterotopen und orthotopen Xenotransplantation von Pavianen, Cynomolgus- und Rhesusaffen mit Landrasse- und hDAF-transgenen Schweineherzen

  2004cites this paper
• Trapianto autologo di cellule staminali periferiche in un paziente con sclerosi sistemica diffusa: nostra esperienza* Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience

  2004cites this paper
• REACTIVE ANTIBODIES WHO ARE AWAITING

  2004cites this paper
• Renal immunology and pathology Renal fibrosis Related review: Novel insights into renal fibrosis

  2003cites this paper
• Allosensitization in heart transplantation: implications and management strategies

  2003cites this paper
• Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide.

  2003cites this paper
• Anti-idiotypic antibodies from highly sensitized patients stimulate B cells to produce anti-HLA antibodies

  2002cites this paper
• High-dose cyclophosphamide for aplastic anemia and autoimmunity

  2002cites this paper
• High Dose Cyclophosphamide Treatment for Autoimmune Disorders

  2002cites this paper
• High-dose cyclophosphamide for refractory autoimmune hemolytic anemia.

  2002cites this paper
• Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic Anemia

  2001cites this paper
• Multilineage glycosylphosphatidylinositol anchor‐deficient haematopoiesis in untreated aplastic anaemia

  2001cites this paper